Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Tempest Therapeutics News

    3,50 $ +0,57% +0,02 $
    In : 3,2727 € | 19:31:18 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3CSM8
    ISIN: US87978U1088
    US-Symbol: TPST
    Typ: Aktie

    Tempest Therapeutics News

    30.01.24 - PR Newswire
    Thinking about buying stock in Agape ATP, Tempest Therapeutics, Nu Holdings, Bristol-Myers Squibb, or Petros Pharmaceuticals?
    Thinking about buying stock in Agape ATP, Tempest Therapeutics, Nu Holdings, Bristol-​Myers Squibb, or Petros Pharmaceuticals? PR Newswire
    27.11.23 - PR Newswire
    Thinking about buying stock in Turnstone Biologics, Iterum Therapeutics, New Gold, GeneDx Holdings, or Tempest Therapeutics?
    Thinking about buying stock in Turnstone Biologics, Iterum Therapeutics, New Gold, GeneDx Holdings, or Tempest Therapeutics? PR Newswire
    07.11.23 - PR Newswire
    Thinking about buying stock in Applied Therapeutics, Coherus Biosciences, Tempest Therapeutics, Bluegreen Vacations Holding, or Adams Resources & Energy?
    Thinking about buying stock in Applied Therapeutics, Coherus Biosciences, Tempest Therapeutics, Bluegreen Vacations Holding, or Adams Resources & Energy? PR Newswire
    02.11.23 - PR Newswire
    Thinking about buying stock in Cybin, Intuitive Machines, Tempest Therapeutics, Plug Power, or OmniLit Acquisition?
    Thinking about buying stock in Cybin, Intuitive Machines, Tempest Therapeutics, Plug Power, or OmniLit Acquisition? PR Newswire
    31.10.23 - PR Newswire
    Thinking about buying stock in Tempest Therapeutics, Applied Digital, Ford Motor, Lockheed Martin, or Motus GI Holdings?
    Thinking about buying stock in Tempest Therapeutics, Applied Digital, Ford Motor, Lockheed Martin, or Motus GI Holdings? PR Newswire
    23.10.23 - PR Newswire
    Thinking about buying stock in XORTX Therapeutics, Tempest Therapeutics, Ginkgo Bioworks Holdings, Athersys, or Textainer Group Holdings?
    Thinking about buying stock in XORTX Therapeutics, Tempest Therapeutics, Ginkgo Bioworks Holdings, Athersys, or Textainer Group Holdings? PR Newswire
    19.10.23 - PR Newswire
    Thinking about buying stock in Tempest Therapeutics, Plug Power, Treasure Global, Firsthand Technology Value Fund, or NXU?
    Thinking about buying stock in Tempest Therapeutics, Plug Power, Treasure Global, Firsthand Technology Value Fund, or NXU? PR Newswire
    18.10.23 - PR Newswire
    Thinking about buying stock in Tempest Therapeutics, VinFast Auto, AGNC Investment, Ardelyx, or Viking Therapeutics?
    Thinking about buying stock in Tempest Therapeutics, VinFast Auto, AGNC Investment, Ardelyx, or Viking Therapeutics? PR Newswire
    13.10.23 - PR Newswire
    Thinking about buying stock in Outset Medical, Tempest Therapeutics, Cassava Sciences, Rivian Automotive, or Athersys?
    Thinking about buying stock in Outset Medical, Tempest Therapeutics, Cassava Sciences, Rivian Automotive, or Athersys? PR Newswire
    13.10.23 - wallstreet:online Zentralredaktion
    Krebsmedikament: Wahnsinns-Rallye: Aktie schießt um 4.000% in die Höhe nach Studien-Erfolg
    Die Titel von Tempest Therapeutics haben eine beispiellose Kursrallye hingelegt nach guten Neuigkeiten zu einem Krebsmedikament. So konnten Anleger aus 1.000 US-Dollar ...
    12.10.23 - Der Aktionär
    Biotech‑Wert Tempest Therapeutics: Plus 3.973 Prozent an einem Tag – und jetzt?
    12.10.23 - wallstreet:online Zentralredaktion
    Krebsmedikament: Aktie klettert 4.000 Prozent nach positiver Medikament-Studie
    Die Titel von Tempest Therapeutics haben eine beispiellose Kursrallye hingelegt nach guten Neuigkeiten zu einem Krebsmedikament. So konnten Anleger aus 1.000 US-Dollar ...
    11.10.23 - Der Aktionär
    Wahnsinn! Krebs‑Biotech macht 3.800 Prozent
    11.10.23 - PR Newswire
    Thinking about buying stock in Beneficient, Femasys, Lucid Group, Tempest Therapeutics, or Ideanomics?
    Thinking about buying stock in Beneficient, Femasys, Lucid Group, Tempest Therapeutics, or Ideanomics? PR Newswire
    15.08.23 - PR Newswire
    Thinking about buying stock in Nikola, Delcath Systems, Taysha Gene Therapies, Tempest Therapeutics, or AGBA Group Holding?
    Thinking about buying stock in Nikola, Delcath Systems, Taysha Gene Therapies, Tempest Therapeutics, or AGBA Group Holding? PR Newswire
    15.07.21 - PR Newswire
    Thinking about buying stock in Verb Technology, Casper Sleep, Millendo Therapeutics, Lipocine, or Hepion Pharmaceuticals?
    Thinking about buying stock in Verb Technology, Casper Sleep, Millendo Therapeutics, Lipocine, or Hepion Pharmaceuticals? PR Newswire
    13.07.21 - PR Newswire
    Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore?
    Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore? PR Newswire
    16.11.18 - PR Newswire
    INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS
    INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS PR Newswire
    04.05.18 - sharedeals.de
    OvaScience vor potenziellem Merger – Buchwert bei 1,60$ je Aktie!
    Wie erwartet erweist sich auch OvaScience (WKN: A1T96P) mehr und mehr als weiterer SD-​Voltreffer. Nach Erstvorstellung vor drei Wochen notiert der Titel zwar aktuell „erst“ +15% ...
    01.12.17 - PR Newswire
    OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm
    OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm PR Newswire

    Newssuche

    Videos

    newspaper
    08:40 Uhr +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »